Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 209178
Company: AUROBINDO PHARMA LTD
Company: AUROBINDO PHARMA LTD
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
IBUPROFEN | IBUPROFEN | 100MG/5ML | SUSPENSION;ORAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
02/16/2018 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
04/28/2021 | SUPPL-7 | Labeling-Package Insert, Labeling-Medication Guide |
Label is not available on this site. |
||
04/13/2021 | SUPPL-6 | Labeling-Package Insert |
Label is not available on this site. |
||
07/22/2019 | SUPPL-4 | Labeling-Package Insert |
Label is not available on this site. |
||
05/18/2018 | SUPPL-2 | Labeling-Container/Carton Labels, Labeling-Package Insert |
Label is not available on this site. |
IBUPROFEN
SUSPENSION;ORAL; 100MG/5ML
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
IBUPROFEN | IBUPROFEN | 100MG/5ML | SUSPENSION;ORAL | Prescription | No | AB | 074978 | ACTAVIS MID ATLANTIC |
IBUPROFEN | IBUPROFEN | 100MG/5ML | SUSPENSION;ORAL | Prescription | No | AB | 209178 | AUROBINDO PHARMA LTD |
IBUPROFEN | IBUPROFEN | 100MG/5ML | SUSPENSION;ORAL | Prescription | No | AB | 076925 | PADAGIS US |
IBUPROFEN | IBUPROFEN | 100MG/5ML | SUSPENSION;ORAL | Prescription | No | AB | 215311 | STRIDES PHARMA |
IBUPROFEN | IBUPROFEN | 100MG/5ML | SUSPENSION;ORAL | Prescription | No | AB | 209204 | TARO |